These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9863953)

  • 1. Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy.
    Mura P; Faucci MT; Manderioli A; Bramanti G; Ceccarelli L
    J Pharm Biomed Anal; 1998 Oct; 18(1-2):151-63. PubMed ID: 9863953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal analysis as a screening technique in preformulation studies of picotamide solid dosage forms.
    Mura P; Faucci MT; Manderioli A; Furlanetto S; Pinzauti S
    Drug Dev Ind Pharm; 1998 Aug; 24(8):747-56. PubMed ID: 9876522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers.
    Cirri M; Mura P; Rabasco AM; Ginés JM; Moyano JR; Gònzalez-Rodrìguez ML
    Drug Dev Ind Pharm; 2004 Jan; 30(1):65-74. PubMed ID: 15000431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems.
    Mura P; Adragna E; Rabasco AM; Moyano JR; Pérez-Martìnez JI; Arias MJ; Ginés JM
    Drug Dev Ind Pharm; 1999 Mar; 25(3):279-87. PubMed ID: 10071820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
    Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
    J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
    Fathy M; Hassan MA; Mohamed FA
    Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility studies of nateglinide with excipients in immediate release tablets.
    Pani NR; Nath LK; Acharya S
    Acta Pharm; 2011 Jun; 61(2):237-47. PubMed ID: 21684850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations.
    Mora PC; Cirri M; Mura P
    J Pharm Biomed Anal; 2006 Sep; 42(1):3-10. PubMed ID: 16574368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of thermal and non thermal techniques for assessing compatibility between mirtazapine and solid lipids.
    Kaur R; Sinha VR
    J Pharm Biomed Anal; 2018 Nov; 161():144-158. PubMed ID: 30149190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of microthermal analysis and photothermal microspectroscopy as novel approaches to drug-excipient compatibility studies.
    Harding L; Qi S; Hill G; Reading M; Craig DQ
    Int J Pharm; 2008 Apr; 354(1-2):149-57. PubMed ID: 18162342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-excipient compatibility studies in binary mixtures of avobenzone.
    Ceresole R; Han YK; Rosasco MA; Orelli LR; Segall A
    J Cosmet Sci; 2013; 64(5):317-28. PubMed ID: 24139431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.
    Late SG; Banga AK
    Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on compatibility assessment of empagliflozin with the selected pharmaceutical excipients employed in solid dosage forms by thermal, spectroscopic and chromatographic techniques.
    Niguram P; Polaka SN; Rathod R; Kalia K; Kate AS
    Drug Dev Ind Pharm; 2020 Feb; 46(2):209-218. PubMed ID: 31933394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility study between acetylcysteine and some commonly used tablet excipients.
    Kerc J; Srcic S; Urleb U; Kanalec A; Kofler B; Smid-Korbar J
    J Pharm Pharmacol; 1992 Jun; 44(6):515-8. PubMed ID: 1359077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility of the antitumoral beta-lapachone with different solid dosage forms excipients.
    Cunha-Filho MS; Martínez-Pacheco R; Landín M
    J Pharm Biomed Anal; 2007 Nov; 45(4):590-8. PubMed ID: 17890039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions.
    Yoshida MI; Gomes EC; Soares CD; Oliveira MA
    Drug Dev Ind Pharm; 2011 Jun; 37(6):638-47. PubMed ID: 21449701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of sennoside A and B with pharmaceutical excipients.
    Verloop Q; Marais AF; de Villiers MM; Liebenberg W
    Pharmazie; 2004 Sep; 59(9):728-30. PubMed ID: 15497761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
    Chadha R; Bhandari S
    J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.